Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.
about
Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Metformin sensitizes triple-ne ...... y suppressing XIAP expression.
@en
Metformin sensitizes triple-ne ...... y suppressing XIAP expression.
@nl
type
label
Metformin sensitizes triple-ne ...... y suppressing XIAP expression.
@en
Metformin sensitizes triple-ne ...... y suppressing XIAP expression.
@nl
prefLabel
Metformin sensitizes triple-ne ...... y suppressing XIAP expression.
@en
Metformin sensitizes triple-ne ...... y suppressing XIAP expression.
@nl
P2860
P1476
Metformin sensitizes triple-ne ...... y suppressing XIAP expression.
@en
P2093
Dmitry Malin
Elena Strekalova
P2860
P2888
P304
P356
10.1007/S10549-017-4201-0
P407
P577
2017-03-21T00:00:00Z